FMO5 and Hyperglycemia: Previous studies have demonstrated that intermittent hyperglycemia activates the NADPH oxidase system, leading to excessive production of reactive oxygen species (ROS), which in turn reduces the bioavailability of nitric oxide (NO) and impairs endothelial vasodilation (19, 24).